Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.06 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |